Deltex Medical: More key endorsements for CardioQ-ODM, says Equity Development
Recent news flow from both sides of the Atlantic has reinforced the case for speeding up the rate which Deltex Medical Group's (LON:DEMG) CardioQ-ODM device is adopted.This is the view of research...
View ArticleDeltex Medical says NCEPOD report supports CardioQ-ODM adoption in NHS – UPDATE
---Adds broker comment from Arden Partners--- Only days after a positive National Health Service (NHS) report, Deltex Medical’s (LON:DEMG) CardioQ-ODM received another endorsement. The company said...
View ArticleDeltex Medical says NCEPOD report supports CardioQ-ODM adoption in NHS
Only days after a positive National Health Service (NHS) report, Deltex Medical’s (LON:DEMG) CardioQ-ODM fluid management technology received another endorsement.The company said today that the...
View ArticleDeltex's CardioQ-ODM endorsed by bladder surgery study
Deltex Medical’s (LON: DEMG) oesophageal Doppler monitor has received another positive endorsement after a new study showed it helped bladder surgery patients recover more quickly. Deltex said the new...
View ArticleDeltex Medical Group entering 2012 with confidence, poised for success in key...
Deltex Medical Group (LON:DEMG), maker of the CardioQ oesophageal Doppler monitoring (ODM) device, said it is entering 2012 with confidence and growing traction in a number of key markets.In the UK,...
View ArticleDeltex Medical’s CardioQ endorsed by UK Department of Health
Medical device maker Deltex Medical Group LON:DEMG) has received a further boost for its oesophageal Doppler monitoring (ODM) technology, this time from the UK Department of Health.The group announced...
View ArticleDeltex Medical wins tender to directly supply NHS hospitals
Deltex Medical Group (LON:DEMG) has been awarded an NHS Supply Chain tender and has launched the new CardioQ-ODM+ monitor for the intensive care market.The group is on the cusp of rolling out its...
View ArticleDeltex Medical Group’s CardioQ device performs well in Canadian trials
Deltex Medical Group (LON:DEMG) said its CardioQ oesophageal Doppler monitoring (ODM) device has performed well while being used in six hospitals in Canada, and the clinical team evaluating the device...
View ArticleDeltex Medical monitor helps reduce complications in abdominal surgery
Deltex Medical Group (LON:DEMG) revealed today that the use of its oesophageal Doppler monitoring system, or ODM, had led to a reduction in a wide range of complications in emergency abdominal surgery....
View ArticleDeltex Medical to raise £1.5 million to meet expected new orders
Deltex Medical Group (LON:DEMG), which makes the CardioQ oesophageal doppler monitoring (ODM) device, is to raise around £1.5 million through a placing so it can meet an expected increase in orders.The...
View ArticleDeltex Medical Group reports increased sales of CardioQ; looks to continued...
Sales in 2012 of its CardioQ oesophageal doppler monitoring (ODM) device so far are ahead of the previous year, Deltex Medical Group (LON:DEMG) will tell shareholders today. Chairman Nigel Keen will...
View ArticleDeltex Medical's CardioQ device sales boosted after NICE recommendation
NHS demand for its surgical probe that monitors the body’s blood flows is starting to gather momentum, Deltex Medical (LON:DEMG) said today. UK sales of the firm’s CardioQ oesophageal Doppler...
View ArticleUPDATE: Deltex Medical sees "step change" as NHS targets big increase in...
---adds audio interview--- Deltex Medical (LON:DEMG) yesterday hailed as a “step change” a new NHS target for a big increase in patients in the south of England using fluid monitoring systems. The move...
View ArticleDeltex Medical expects NHS roll-out details by Christmas
Deltex Medical (LON:DEMG) expects details for the first phase of the NHS’s planned national roll-out of fluid management monitoring to be published by Christmas. Ewan Phillips, chief executive, said...
View ArticleDeltex Medical 's ODM endorsed by new European study
Deltex Medical (LON:DEMG) has highlighted more research from Europe that indicates the use of oesophageal Doppler monitoring (ODM) significantly boosts a patient’s recovery after surgery. A review of...
View ArticleDeltex Medical looks to capitalise on growing body of evidence
An NHS delay held back Deltex Medical’s (LON:DEMG) top-line growth in 2012 but the company enters 2013 in bullish mood. The oesophageal Doppler monitor (ODM) maker’s group sales in 2012 rose to £6.8mln...
View ArticleDeltex Medical Group raises funds to finance collaboration with Premier
Deltex Medical Group (LON:DEMG) is to raise £2.5mln through a placing of shares at 19p each.The global leader in oesophageal Doppler monitoring said the funds will be used to finance the second phase...
View ArticleDeltex Medical Group sees barrier to US up-take removed
-- Adds comments from CEO and FD -- Deltex Medical Group (LON:DEMG) has seen the removal of a significant barrier to up-take of its oesophageal Doppler monitoring (ODM) system in the US. The US Centres...
View ArticleDeltex Medical sees pick up in surgical probe sales
Strong sales of surgical probes to the NHS and elsewhere enabled oesophageal doppler monitoring (ODM) specialist Deltex Medical (LON:DEMG) to increase revenues by 9% in 2012. Trading in the early part...
View ArticleDeltex Medical reports strong sales for start of year
Deltex Medical Group (LON:DEMG) told investors that probe sales have started well this year and it expects further progress throughout 2013. The firm is generating substantial cash returns from sales...
View ArticleDeltex Medical Group welcomes guidelines from French medical body
New guidelines for anaesthetists in France have given a boost to oesophageal Doppler monitoring (ODM) system provider Deltex Medical (LON:DEMG). Guidelines published by the Société Française...
View ArticleDeltex Medical sees Duke University results as US springboard
Deltex Medical’s (LON:DEMG) expects more US hospitals to trial its ODM blood flow monitor after the result of a pilot in North Carolina showed substantial benefits. The results of the pilot study,...
View ArticleDeltex Medical expects US launch in second half
Deltex Medical (LON:DEMG) expects to launch its blood-flow monitoring device CardioQ-ODM+ in the USA in the second half of 2013. It has completed its submission to the US Food & Drug Administration...
View ArticleDeltex unveils positive results from St Thomas's study
Deltex Medical Group (LON:DEMG) has revealed positive results from a study where its CardioQ-ODM blood flow monitoring system was used in post-operative care. A total of 84 “awake” patients recovering...
View ArticleDeltex Medical reports strong probe sales in latest half year
Deltex Medical (LON:DEMG) has reported strong growth in surgical probe revenues in its latest half year. In the UK, sales were up 14% in the six months to June 30, and more than 30% in the second...
View ArticleUPDATE - Deltex Medical's UK sales get shot in the arm
---ADDS MANAGEMENT COMMENTS AND SHARE PRICE--- Oesophageal Doppler monitoring (ODM) specialist Deltex Medical’s (LON:DEMG) saw sales of surgical probes to the NHS and US hospitals pick up smartly in...
View ArticleUPDATE - Deltex Medical gets US green light for combined flow and pressure...
--ADDS ADDITIONAL COMMENTS--Deltex Medical (LON:DEMG) has launched its CardioQ-ODM+ monitor in the US after receiving marketing approval from the Food and Drug Administration (FDA). Launched in Europe...
View ArticleDeltex Medical Group settles US loan with share issue
Deltex (LON:DEMG) has issued a total of 2.86mln shares at 13.75p each following conversion of a loan held in the US subsidiary. The newly issued shares represent 1.67% of the share capital of the...
View ArticleDeltex Medical gets France renewal boost
Deltex Medical‘s (LON:DEMG) French partner, Gamida, has had its contract to supply the public hospital system in Paris renewed for another four years. Sales of surgical probes for Deltex’s CardioQ-ODM...
View ArticleDeltex Medical ties up marketing deal for Pacific region with Australian peer
Deltex Medical (LON:DEMG) aims to boost its presence in Asia and the Pacific region through a marketing and distribution agreement with Australian firm Uscom. Uscom, which manufactures and markets a...
View Article
